Lind, placebocontrolled trial of ruxolitinib for myelofibrosis. N Engl J Med.
Lind, placebocontrolled trial of ruxolitinib for myelofibrosis. N Engl J Med. 2012; 366(9):799?07. 12. Harrison C, Kiladjian JJ, Al-Ali HK, et al. JAK inhibition with ruxolitinib versus very best obtainable…